TNF and COVID-19: Furthermore, the results of another cross-sectional study were “not satisfactory.” When comparing the immune status of patients with COVID-19 in the PS group and SM group at the initial stage of severe disease, the only discernible difference between the two groups was in the expression of TNF-α in plasma.